Spero Therapeutics, Inc.SPRO決算レポート
Nasdaq · ヘルスケア · 医薬製剤
主要株主
| 株主 | 保有比率 | 株数 | 変動 | 基準日 |
|---|---|---|---|---|
| OF ABOVE PERSONS | 6.90% | 3.8M | ▼ -1.20pp | 2024-11-14 |
インサイダー取引
Net 90d: −$311.1K · buys $0 / sells $311.1K期間:
種別:
役職:
| インサイダー | 役職 | 種別 | ||||
|---|---|---|---|---|---|---|
| 2026-02-06 | Timothy Keutzer | Chief Operating Officer | Sell (open market) | 18.7K | $2.36 | $44.0K |
| 2026-02-06 | Esther Rajavelu | See Remarks | Sell (open market) | 37.1K | $2.36 | $87.6K |
| 2026-02-06 | Esther Rajavelu | See Remarks | Sell (open market) | 50.8K | $2.36 | $119.9K |
| 2026-02-04 | Timothy Keutzer | Chief Operating Officer | Sell (open market) | 3.5K | $2.24 | $7.8K |
| 2026-02-03 | Timothy Keutzer | Chief Operating Officer | Sell (open market) | 24.2K | $2.14 | $51.8K |
1–5 of 5